Name | Value |
---|---|
Revenues | 6,213.0K |
Cost of Revenue | 3,681.0K |
Gross Profit | 2,532.0K |
Operating Expense | 6,154.0K |
Operating I/L | -3,071.0K |
Other Income/Expense | 0.0K |
Interest Income | 0.0K |
Pretax | -3,071.0K |
Income Tax Expense | 305.0K |
Net Income/Loss | -3,376.0K |
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company that researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits to life science researchers for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians. The Therapeutics segment develops novel approaches in various disease areas.